ATP7B gene therapy (Oxford Biomedica)

N/A

Report date: 2025/01/26 19:29:45

Base Information

Drug NameATP7B gene therapy (Oxford Biomedica)
Drug Alias NameSupA2KO-HSP-tbs-ATP7Blentiviral vector-based gene therapy (Oxford Biomedica)
ClassificationBiologics
Mechanisms of ActionCopper-transporting ATPase 2 gene transference
TargetsCopper-transporting ATPase 2
Therapy Area/IndicationsHepatolenticular Degeneration
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesOxford Biomedica PLC
China Registration ClassN/A

Develop Information

Active CompaniesOxford Biomedica PLC
Inactive CompaniesN/A
Active IndicationsHepatolenticular Degeneration
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A